<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02332707</url>
  </required_header>
  <id_info>
    <org_study_id>3682-011</org_study_id>
    <secondary_id>2014-003304-73</secondary_id>
    <secondary_id>MK-3682-011</secondary_id>
    <nct_id>NCT02332707</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)</brief_title>
  <official_title>A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-3682 With Either MK-8742 or MK-8408 in Subjects With Chronic HCV GT1 and GT2 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, three-part, open-label trial of grazoprevir (GZR; MK-5172) (100 mg) and
      uprifosbuvir (UPR; MK-3682) (300 mg or 450 mg), with either elbasvir (EBR; MK-8742) (50 mg)
      or ruzasvir (RZR; MK-8408) (60 mg), and with or without ribavirin (RBV), in treatment-naïve
      (TN) cirrhotic (C) or non-cirrhotic (NC) hepatitis C virus (HCV) participants with chronic
      HCV genotype (GT) 1 or GT2 infection. Part A will consist of 8 arms to evaluate the safety of
      dose combinations. In Part B, participants will take 2 UPR+GZR+RZR fixed dose combination
      (FDC) tablets once daily (q.d.) by mouth, with or without twice-daily (b.i.d.) RBV (200 mg
      capsules; weight-based dosing). Participants who relapse following completion of therapy in
      Part A will be offered the option of retreatment with 16 weeks of UPR+GZR+RZR with RBV in
      Part C (data obtained from Part C will not be used in the analysis of outcome measures).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In Part A, study therapy will be administered as separate products, each taken q.d. by mouth.
      In Part B and Part C, participants will take 2 FDC tablets containing UPR 225 mg + GZR 50 mg
      + RZR 30 mg q.d. by mouth.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 22, 2015</start_date>
  <completion_date type="Actual">December 6, 2016</completion_date>
  <primary_completion_date type="Actual">September 16, 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants Achieving Sustained Virologic Response 12 Weeks After Completing Treatment (SVR12)</measure>
    <time_frame>Up to 28 weeks</time_frame>
    <description>The percentage of participants with Hepatitis C virus (HCV) ribonucleic acid (RNA) &lt; Lower Limit of Quantification (LLoQ) 12 weeks after completing treatment (i.e., SVR12) in each arm was determined. Plasma levels of HCV RNA levels were measured using the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV Test, v2.0 assay, which has a LLoQ of 15 IU/mL.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants Experiencing an Adverse Event (AE)</measure>
    <time_frame>Up to 18 weeks</time_frame>
    <description>An AE is defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants Discontinuing From Study Treatment Due to an AE</measure>
    <time_frame>Up to 16 weeks</time_frame>
    <description>An AE is defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving Sustained Virologic Response 24 Weeks After Ending Study Treatment (SVR24)</measure>
    <time_frame>Up to 40 weeks</time_frame>
    <description>The percentage of participants with HCV RNA &lt; LLoQ 24 weeks after completing treatment (i.e., SVR24) in each arm was determined. Plasma levels of HCV RNA levels were measured using the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV Test, v2.0 assay, which has a LLoQ of 15 IU/mL.</description>
  </secondary_outcome>
  <number_of_arms>18</number_of_arms>
  <enrollment type="Actual">443</enrollment>
  <condition>Hepatitis C</condition>
  <arm_group>
    <arm_group_label>A1: GT1 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part A, HCV GT1-infected NC participants will take GZR 100 mg + UPR 300 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A2: GT1 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part A, HCV GT1-infected NC participants will take GZR 100 mg + UPR 300 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A3: GT2 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part A, HCV GT2-infected NC participants will take GZR 100 mg + UPR 300 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A4: GT2 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part A, HCV GT2-infected NC participants will take GZR 100 mg + UPR 300 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A5: GT1 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part A, HCV GT1-infected NC participants will take GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A6: GT1 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part A, HCV GT1-infected NC participants will take GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B7: GT2 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part A, HCV GT2-infected NC participants will take GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A8: GT2 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part A, HCV GT2-infected NC participants will take GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks. In Part B, HCV GT2-infected NC participants will take 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B9: GT1 NC GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part B, HCV GT1-infected NC participants will take 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B10: GT2 NC GZR+UPR+RZR (8 weeks) + RBV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part B, HCV GT2-infected NC participants will take 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B11: GT2 NC GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part B, HCV GT2-infected NC participants will take 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B12: GT1 C GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part B, HCV GT1-infected C participants will take 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B13: GT1 C GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part B, HCV GT1-infected C participants will take 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B14: GT2 C GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part B, HCV GT2-infected C participants will take 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B15: GT2 C GZR+UPR+RZR (12 weeks) + RBV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part B, HCV GT2-infected C participants will take 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B16: GT2 C GZR+UPR+RZR (16 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part B, HCV GT2-infected C participants will take 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 16 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B6: GT1 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part B, HCV GT1-infected NC participants will take 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B8: GT2 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part B, HCV GT2-infected NC participants will take 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Grazoprevir</intervention_name>
    <description>One GZR 100 mg tablet (Part A), or 2 FDC tablets containing GZR 50 mg per tablet (Part B), taken q.d.by mouth.</description>
    <arm_group_label>A1: GT1 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_label>A2: GT1 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>A3: GT2 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_label>A4: GT2 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>A5: GT1 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_label>A6: GT1 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>B7: GT2 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_label>A8: GT2 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>B9: GT1 NC GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B10: GT2 NC GZR+UPR+RZR (8 weeks) + RBV</arm_group_label>
    <arm_group_label>B11: GT2 NC GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B12: GT1 C GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>B13: GT1 C GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B14: GT2 C GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B15: GT2 C GZR+UPR+RZR (12 weeks) + RBV</arm_group_label>
    <arm_group_label>B16: GT2 C GZR+UPR+RZR (16 weeks)</arm_group_label>
    <other_name>MK-5172</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Uprifosbuvir</intervention_name>
    <description>Two or 3 UPR 150 mg (300 mg and 450 mg total daily dose) tablets (Part A), or 2 FDC tablets containing UPR 225 mg (Part B), taken q.d. by mouth.</description>
    <arm_group_label>A1: GT1 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_label>A2: GT1 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>A3: GT2 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_label>A4: GT2 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>A5: GT1 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_label>A6: GT1 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>B7: GT2 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_label>A8: GT2 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>B9: GT1 NC GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B10: GT2 NC GZR+UPR+RZR (8 weeks) + RBV</arm_group_label>
    <arm_group_label>B11: GT2 NC GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B12: GT1 C GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>B13: GT1 C GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B14: GT2 C GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B15: GT2 C GZR+UPR+RZR (12 weeks) + RBV</arm_group_label>
    <arm_group_label>B16: GT2 C GZR+UPR+RZR (16 weeks)</arm_group_label>
    <other_name>MK-3682</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Elbasvir</intervention_name>
    <description>One EBR 50 mg tablet (Part A), taken q.d. by mouth.</description>
    <arm_group_label>A1: GT1 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_label>A3: GT2 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_label>A5: GT1 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <arm_group_label>B7: GT2 NC GZR+UPR+EBR (8 weeks)</arm_group_label>
    <other_name>MK-8742</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ruzasvir</intervention_name>
    <description>Six RZR 10 mg (60 mg total daily dose) capsules (Part A), or 2 FDC tablets containing RZR 30 mg per tablet (Part B), taken q.d. by mouth.</description>
    <arm_group_label>A2: GT1 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>A4: GT2 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>A6: GT1 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>A8: GT2 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>B9: GT1 NC GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B10: GT2 NC GZR+UPR+RZR (8 weeks) + RBV</arm_group_label>
    <arm_group_label>B11: GT2 NC GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B12: GT1 C GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>B13: GT1 C GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B14: GT2 C GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B15: GT2 C GZR+UPR+RZR (12 weeks) + RBV</arm_group_label>
    <arm_group_label>B16: GT2 C GZR+UPR+RZR (16 weeks)</arm_group_label>
    <other_name>MK-8408</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Uprifosbuvir (+) Grazoprevir (+) Ruzasvir</intervention_name>
    <description>Two FDC tablets, each containing GZR 50 mg + UPR 225 mg + RZR 30 mg (Part B), taken q.d. by mouth.</description>
    <arm_group_label>B9: GT1 NC GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B10: GT2 NC GZR+UPR+RZR (8 weeks) + RBV</arm_group_label>
    <arm_group_label>B11: GT2 NC GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B12: GT1 C GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>B13: GT1 C GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B14: GT2 C GZR+UPR+RZR (12 weeks)</arm_group_label>
    <arm_group_label>B15: GT2 C GZR+UPR+RZR (12 weeks) + RBV</arm_group_label>
    <arm_group_label>B16: GT2 C GZR+UPR+RZR (16 weeks)</arm_group_label>
    <arm_group_label>B6: GT1 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <arm_group_label>B8: GT2 NC GZR+UPR+RZR (8 weeks)</arm_group_label>
    <other_name>MK-3682B</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ribavirin</intervention_name>
    <description>RBV 200 mg capsules taken b.i.d. at a total daily dose of 800-1400 mg based on participant body weight.</description>
    <arm_group_label>B10: GT2 NC GZR+UPR+RZR (8 weeks) + RBV</arm_group_label>
    <arm_group_label>B15: GT2 C GZR+UPR+RZR (12 weeks) + RBV</arm_group_label>
    <other_name>Rebetol®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Parts A and B:

          -  Previously untreated chronic HCV GT1 or GT2 with no evidence of non-typeable or mixed
             genotype infection

          -  Has HCV ribonucleic acid (RNA) &gt;= 10,000 IU/mL in peripheral blood at the time of
             screening

          -  Is NC (Part A and B)

          -  Is HCV treatment naïve (defined as no prior exposure to any interferon, ribavirin, or
             other approved or experimental HCV-specific direct-acting antiviral agent

          -  Is of non-childbearing potential or agrees to avoid becoming pregnant or impregnating
             a partner beginning at least 2 weeks prior to administration of the initial dose of
             study drug and either for 14 days after the last dose of study drug if not taking RBV
             or for 6 months after the last dose of study drug if taking RBV (or longer if dictated
             by local regulations). If not abstinent from heterosexual activity, participants in
             Part A must use 2 acceptable forms of barrier contraception whereas participants in
             Part B must use 2 acceptable forms of contraception which may include oral
             contraceptives

        Part B only:

          -  Has cirrhosis of the liver

          -  If coinfected with human immunodeficiency virus (HIV) is not currently on
             antiretroviral therapy (ART) and has no plans to initiate ART treatment while
             participating in this study OR has well controlled HIV on ART (the ART regimen must
             contain only the following antiretroviral medications: tenofovir, abacavir,
             lamivudine, emtricitabine, raltegravir, dolutegravir, and rilpivirine with no dose
             modifications or changes in drugs in the 4 weeks prior to study entry [Day 1])

          -  Has at least one viable ART regimen alternative beyond their current regimen in the
             event of HIV virologic failure and the development of antiretroviral drug resistance

        Exclusion Criteria:

        Parts A, B, and C (unless noted otherwise):

          -  Has evidence of decompensated liver disease manifested by the presence of or history
             of ascites, esophageal or gastric variceal bleeding, hepatic encephalopathy or other
             signs or symptoms of advanced liver disease

          -  For cirrhotics (Part B only), participants who are Child-Pugh Class B or C or who have
             a Pugh-Turcotte (CPT) score &gt;5

          -  Is coinfected with hepatitis B virus

          -  Is coinfected with HIV (Part A only)

          -  If coinfected with HIV (Part B only), has a history of opportunistic infection in the
             preceding 6 months prior to screening

          -  Has a history of malignancy &lt;=5 years prior to signing informed consent except for
             adequately treated basal cell or squamous cell skin cancer or in situ cervical cancer
             or carcinoma in situ; or is under evaluation for other active or suspected malignancy

          -  Has cirrhosis and has had liver imaging within 6 months of Day 1 showing evidence of
             hepatocellular carcinoma (HCC) or is under evaluation for HCC

          -  Has clinically-relevant drug or alcohol abuse within 12 months of screening

          -  Pregnant or breast-feeding, or expecting to conceive or donate eggs from at least 2
             weeks prior to Day 1 and 90 days after the last dose of study medication, or longer if
             dictated by local regulations

          -  Has any of the following conditions:

          -  organ transplants (including hematopoietic stem cell transplants) other than cornea
             and hair

          -  poor venous access that precludes routine peripheral blood sampling required for this
             trial

          -  has a history of gastric surgery (e.g., stapling, bypass) or history of malabsorption
             disorders (e.g., celiac sprue disease)

          -  current or history of any clinically significant cardiac abnormalities/dysfunction,
             including but not limited to: angina, congestive heart failure, myocardial infarction,
             pulmonary hypertension, complex congenital heart disease, cardiomyopathy, significant
             arrhythmia, uncontrolled hypertension, a history of use of antianginal or
             anti-arrhythmic agents for cardiac conditions, prolonged electrocardiogram (ECG) QTc
             interval (&gt;470 ms for males or &gt;480 ms for females by the Fridericia formula) at the
             screening visit, personal or family history of Torsade de pointes

          -  chronic pulmonary disease, including but not limited to: clinically significant
             chronic obstructive pulmonary disease, interstitial lung disease, pulmonary fibrosis,
             sarcoidosis

          -  central nervous system (CNS) trauma requiring intubation, intracranial pressure
             monitoring, brain meningeal or skull surgery, or resulting in seizure, coma, permanent
             neurologic deficits, abnormal brain imaging, or cerebral spinal fluid (CSF) leak.
             Prior brain hemorrhage and/or intracranial aneurysms (whether adequately repaired or
             not)

          -  a current, or history of, seizure disorder unless seizure was &gt;10 years ago, a single
             isolated event, no history of or current use of anti-seizure medications prescribed,
             and a normal neurological examination is documented in trial files within 6 months of
             Day 1

          -  a history of stroke or transient ischemic attack

          -  a history of a medical/surgical condition that resulted in hospitalization within the
             3 months prior to enrollment, other than for minor elective procedures

          -  a medical/surgical conditions that may result in a need for hospitalization during the
             period of the study

          -  any medical condition requiring, or likely to require, chronic systemic administration
             of corticosteroids, tumor necrosis factor (TNF) antagonists, or other
             immunosuppressant drugs during the course of the trial

          -  has any condition, prestudy laboratory or ECG abnormality or history of any illness,
             which, in the opinion of the investigator, might confound the results of the study or
             pose additional risk in administering the study drugs to the subject

          -  experiences a life-threatening serious adverse event (SAE) during the screening period

          -  evidence of history of chronic hepatitis not caused by HCV, including but not limited
             to nonalcoholic steatohepatitis (NASH), drug-induced hepatitis, hemochromatosis,
             Wilson's disease, α1-antitrypsin deficiency, alcoholic liver disease, and autoimmune
             hepatitis

          -  hemoglobinopathy, including, but not limited to, thalassemia major (Parts B and C
             only) Parts B and C only: is a male whose female partner(s) is/are pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <removed_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Canada</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Lithuania</country>
    <country>New Zealand</country>
    <country>Poland</country>
    <country>Puerto Rico</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </removed_countries>
  <results_reference>
    <citation>Lawitz E, Buti M, Vierling JM, Almasio PL, Bruno S, Ruane PJ, Hassanein TI, Muellhaupt B, Pearlman B, Jancoriene L, Gao W, Huang HC, Shepherd A, Tannenbaum B, Fernsler D, Li JJ, Grandhi A, Liu H, Su FH, Wan S, Dutko FJ, Nguyen BT, Wahl J, Robertson MN, Barr E, Yeh WW, Plank RM, Butterton JR, Yoshida EM. Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials. Lancet Gastroenterol Hepatol. 2017 Nov;2(11):814-823. doi: 10.1016/S2468-1253(17)30163-2. Epub 2017 Aug 10.</citation>
    <PMID>28802814</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2015</study_first_submitted>
  <study_first_submitted_qc>January 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2015</study_first_posted>
  <results_first_submitted>November 28, 2017</results_first_submitted>
  <results_first_submitted_qc>November 28, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">December 21, 2017</results_first_posted>
  <last_update_submitted>January 22, 2018</last_update_submitted>
  <last_update_submitted_qc>January 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ribavirin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This trial was conducted at 95 study sites in Asia, the European Union, and North America.</recruitment_details>
      <pre_assignment_details>The &quot;Number Started&quot; row reflects the number of randomized participants who received study treatment. A total of 443 participants were randomized but 1 participant withdrew consent prior to receiving any study treatment.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>A1: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
          <description>In Part A, Hepatitis C virus (HCV) genotype (GT)1-infected non-cirrhotic (NC) participants took grazoprevir (GZR) 100 mg + uprifosbuvir (UPR) 300 mg + elbasvir (EBR) 50 mg once daily (q.d.) by mouth for 8 weeks.</description>
        </group>
        <group group_id="P2">
          <title>A2: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 300 mg + ruzasvir (RZR) 60 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="P3">
          <title>A3: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
          <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="P4">
          <title>A4: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="P5">
          <title>A5: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
          <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="P6">
          <title>A6: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="P7">
          <title>A7: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
          <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="P8">
          <title>A8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="P9">
          <title>B9: GT1 NC GZR+UPR+RZR (12 Weeks)</title>
          <description>In Part B, HCV GT1-infected NC participants took 2 fixed dose combination (FDC) tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
        </group>
        <group group_id="P10">
          <title>B10: GT2 NC GZR+UPR+RZR (8 Weeks) + RBV</title>
          <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
        </group>
        <group group_id="P11">
          <title>B11: GT2 NC GZR+UPR+RZR (12 Weeks)</title>
          <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
        </group>
        <group group_id="P12">
          <title>B12: GT1 C GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="P13">
          <title>B13: GT1 C GZR+UPR+RZR (12 Weeks)</title>
          <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
        </group>
        <group group_id="P14">
          <title>B14: GT2 C GZR+UPR+RZR (12 Weeks)</title>
          <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
        </group>
        <group group_id="P15">
          <title>B15: GT2 C GZR+UPR+RZR (12 Weeks) + RBV</title>
          <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
        </group>
        <group group_id="P16">
          <title>B16: GT2 C GZR+UPR+RZR (16 Weeks)</title>
          <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 16 weeks.</description>
        </group>
        <group group_id="P17">
          <title>B6: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part B, HCV GT1-infected NC participants took 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="P18">
          <title>B8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="16"/>
                <participants group_id="P4" count="14"/>
                <participants group_id="P5" count="23"/>
                <participants group_id="P6" count="23"/>
                <participants group_id="P7" count="15"/>
                <participants group_id="P8" count="16"/>
                <participants group_id="P9" count="48"/>
                <participants group_id="P10" count="31"/>
                <participants group_id="P11" count="31"/>
                <participants group_id="P12" count="35"/>
                <participants group_id="P13" count="40"/>
                <participants group_id="P14" count="15"/>
                <participants group_id="P15" count="16"/>
                <participants group_id="P16" count="26"/>
                <participants group_id="P17" count="30"/>
                <participants group_id="P18" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="13"/>
                <participants group_id="P5" count="23"/>
                <participants group_id="P6" count="22"/>
                <participants group_id="P7" count="15"/>
                <participants group_id="P8" count="16"/>
                <participants group_id="P9" count="48"/>
                <participants group_id="P10" count="28"/>
                <participants group_id="P11" count="29"/>
                <participants group_id="P12" count="35"/>
                <participants group_id="P13" count="35"/>
                <participants group_id="P14" count="15"/>
                <participants group_id="P15" count="16"/>
                <participants group_id="P16" count="26"/>
                <participants group_id="P17" count="30"/>
                <participants group_id="P18" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="3"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="5"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="3"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="3"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The Baseline Population consists of all randomized participants who received study medication.</population>
      <group_list>
        <group group_id="B1">
          <title>A1: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
          <description>In Part A, Hepatitis C virus (HCV) genotype (GT)1-infected non-cirrhotic (NC) participants took grazoprevir (GZR) 100 mg + uprifosbuvir (UPR) 300 mg + elbasvir (EBR) 50 mg once daily (q.d.) by mouth for 8 weeks.</description>
        </group>
        <group group_id="B2">
          <title>A2: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 300 mg + ruzasvir (RZR) 60 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="B3">
          <title>A3: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
          <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="B4">
          <title>A4: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="B5">
          <title>A5: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
          <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="B6">
          <title>A6: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="B7">
          <title>A7: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
          <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="B8">
          <title>A8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="B9">
          <title>B9: GT1 NC GZR+UPR+RZR (12 Weeks)</title>
          <description>In Part B, HCV GT1-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
        </group>
        <group group_id="B10">
          <title>B10: GT2 NC GZR+UPR+RZR (8 Weeks) + RBV</title>
          <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
        </group>
        <group group_id="B11">
          <title>B11: GT2 NC GZR+UPR+RZR (12 Weeks)</title>
          <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
        </group>
        <group group_id="B12">
          <title>B12: GT1 C GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="B13">
          <title>B13: GT1 C GZR+UPR+RZR (12 Weeks)</title>
          <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
        </group>
        <group group_id="B14">
          <title>B14: GT2 C GZR+UPR+RZR (12 Weeks)</title>
          <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
        </group>
        <group group_id="B15">
          <title>B15: GT2 C GZR+UPR+RZR (12 Weeks) + RBV</title>
          <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
        </group>
        <group group_id="B16">
          <title>B16: GT2 C GZR+UPR+RZR (16 Weeks)</title>
          <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 16 weeks.</description>
        </group>
        <group group_id="B17">
          <title>B6: GT1 NC GZR+UPR+RVR (8 Weeks)</title>
          <description>In Part B, HCV GT1-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="B18">
          <title>B8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="B19">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
            <count group_id="B2" value="24"/>
            <count group_id="B3" value="16"/>
            <count group_id="B4" value="14"/>
            <count group_id="B5" value="23"/>
            <count group_id="B6" value="23"/>
            <count group_id="B7" value="15"/>
            <count group_id="B8" value="16"/>
            <count group_id="B9" value="48"/>
            <count group_id="B10" value="31"/>
            <count group_id="B11" value="31"/>
            <count group_id="B12" value="35"/>
            <count group_id="B13" value="40"/>
            <count group_id="B14" value="15"/>
            <count group_id="B15" value="16"/>
            <count group_id="B16" value="26"/>
            <count group_id="B17" value="30"/>
            <count group_id="B18" value="16"/>
            <count group_id="B19" value="442"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.2" spread="13.5"/>
                    <measurement group_id="B2" value="45.0" spread="14.5"/>
                    <measurement group_id="B3" value="49.4" spread="15.8"/>
                    <measurement group_id="B4" value="52.6" spread="11.6"/>
                    <measurement group_id="B5" value="49.0" spread="11.2"/>
                    <measurement group_id="B6" value="46.7" spread="13.9"/>
                    <measurement group_id="B7" value="52.9" spread="12.1"/>
                    <measurement group_id="B8" value="48.3" spread="8.8"/>
                    <measurement group_id="B9" value="48.8" spread="13.9"/>
                    <measurement group_id="B10" value="49.8" spread="13.0"/>
                    <measurement group_id="B11" value="55.6" spread="14.4"/>
                    <measurement group_id="B12" value="58.8" spread="9.6"/>
                    <measurement group_id="B13" value="56.9" spread="11.1"/>
                    <measurement group_id="B14" value="61.8" spread="6.8"/>
                    <measurement group_id="B15" value="59.8" spread="8.0"/>
                    <measurement group_id="B16" value="64.0" spread="9.3"/>
                    <measurement group_id="B17" value="47.4" spread="11.7"/>
                    <measurement group_id="B18" value="51.4" spread="10.8"/>
                    <measurement group_id="B19" value="52.6" spread="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="14"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="9"/>
                    <measurement group_id="B8" value="8"/>
                    <measurement group_id="B9" value="21"/>
                    <measurement group_id="B10" value="16"/>
                    <measurement group_id="B11" value="16"/>
                    <measurement group_id="B12" value="14"/>
                    <measurement group_id="B13" value="11"/>
                    <measurement group_id="B14" value="3"/>
                    <measurement group_id="B15" value="4"/>
                    <measurement group_id="B16" value="9"/>
                    <measurement group_id="B17" value="14"/>
                    <measurement group_id="B18" value="9"/>
                    <measurement group_id="B19" value="192"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="14"/>
                    <measurement group_id="B7" value="6"/>
                    <measurement group_id="B8" value="8"/>
                    <measurement group_id="B9" value="27"/>
                    <measurement group_id="B10" value="15"/>
                    <measurement group_id="B11" value="15"/>
                    <measurement group_id="B12" value="21"/>
                    <measurement group_id="B13" value="29"/>
                    <measurement group_id="B14" value="12"/>
                    <measurement group_id="B15" value="12"/>
                    <measurement group_id="B16" value="17"/>
                    <measurement group_id="B17" value="16"/>
                    <measurement group_id="B18" value="7"/>
                    <measurement group_id="B19" value="250"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Achieving Sustained Virologic Response 12 Weeks After Completing Treatment (SVR12)</title>
        <description>The percentage of participants with Hepatitis C virus (HCV) ribonucleic acid (RNA) &lt; Lower Limit of Quantification (LLoQ) 12 weeks after completing treatment (i.e., SVR12) in each arm was determined. Plasma levels of HCV RNA levels were measured using the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV Test, v2.0 assay, which has a LLoQ of 15 IU/mL.</description>
        <time_frame>Up to 28 weeks</time_frame>
        <population>All randomized participants who received at least 1 dose of study drug and had SVR12 results available are included.</population>
        <group_list>
          <group group_id="O1">
            <title>A1: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, Hepatitis C virus (HCV) genotype (GT)1-infected non-cirrhotic (NC) participants took grazoprevir (GZR) 100 mg + uprifosbuvir (UPR) 300 mg + elbasvir (EBR) 50 mg once daily (q.d.) by mouth for 8 weeks.</description>
          </group>
          <group group_id="O2">
            <title>A2: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 300 mg + ruzasvir (RZR) 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O3">
            <title>A3: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O4">
            <title>A4: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O5">
            <title>A5: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O6">
            <title>A6: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O7">
            <title>B6: GT1 NC GZR+UPR+RVR (8 Weeks)</title>
            <description>In Part B, HCV GT1-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O8">
            <title>A7: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O9">
            <title>A8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O10">
            <title>B8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O11">
            <title>B9: GT1 NC GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT1-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O12">
            <title>B10: GT2 NC GZR+UPR+RZR (8 Weeks) + RBV</title>
            <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
          </group>
          <group group_id="O13">
            <title>B11: GT2 NC GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O14">
            <title>B12: GT1 C GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O15">
            <title>B13: GT1 C GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O16">
            <title>B14: GT2 C GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O17">
            <title>B15: GT2 C GZR+UPR+RZR (12 Weeks) + RBV</title>
            <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
          </group>
          <group group_id="O18">
            <title>16: GT2 C GZR+UPR+RZR (16 Weeks)</title>
            <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 16 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving Sustained Virologic Response 12 Weeks After Completing Treatment (SVR12)</title>
          <description>The percentage of participants with Hepatitis C virus (HCV) ribonucleic acid (RNA) &lt; Lower Limit of Quantification (LLoQ) 12 weeks after completing treatment (i.e., SVR12) in each arm was determined. Plasma levels of HCV RNA levels were measured using the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV Test, v2.0 assay, which has a LLoQ of 15 IU/mL.</description>
          <population>All randomized participants who received at least 1 dose of study drug and had SVR12 results available are included.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="23"/>
                <count group_id="O6" value="23"/>
                <count group_id="O7" value="30"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="16"/>
                <count group_id="O10" value="16"/>
                <count group_id="O11" value="48"/>
                <count group_id="O12" value="30"/>
                <count group_id="O13" value="30"/>
                <count group_id="O14" value="35"/>
                <count group_id="O15" value="39"/>
                <count group_id="O16" value="15"/>
                <count group_id="O17" value="16"/>
                <count group_id="O18" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O3" value="68.8" lower_limit="41.3" upper_limit="89.0"/>
                    <measurement group_id="O4" value="71.4" lower_limit="41.9" upper_limit="91.6"/>
                    <measurement group_id="O5" value="100.0" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O6" value="91.3" lower_limit="72.0" upper_limit="98.9"/>
                    <measurement group_id="O7" value="100.0" lower_limit="88.4" upper_limit="100.0"/>
                    <measurement group_id="O8" value="60.0" lower_limit="32.3" upper_limit="83.7"/>
                    <measurement group_id="O9" value="93.8" lower_limit="69.8" upper_limit="99.8"/>
                    <measurement group_id="O10" value="87.5" lower_limit="61.7" upper_limit="98.4"/>
                    <measurement group_id="O11" value="100.0" lower_limit="92.6" upper_limit="100.0"/>
                    <measurement group_id="O12" value="83.3" lower_limit="65.3" upper_limit="94.4"/>
                    <measurement group_id="O13" value="100.0" lower_limit="88.4" upper_limit="100.0"/>
                    <measurement group_id="O14" value="97.1" lower_limit="85.1" upper_limit="99.9"/>
                    <measurement group_id="O15" value="100.0" lower_limit="91.0" upper_limit="100.0"/>
                    <measurement group_id="O16" value="100.0" lower_limit="78.2" upper_limit="100.0"/>
                    <measurement group_id="O17" value="100.0" lower_limit="79.4" upper_limit="100.0"/>
                    <measurement group_id="O18" value="100.0" lower_limit="86.3" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Experiencing an Adverse Event (AE)</title>
        <description>An AE is defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment.</description>
        <time_frame>Up to 18 weeks</time_frame>
        <population>All randomized participants who received at least 1 dose of study drug are included.</population>
        <group_list>
          <group group_id="O1">
            <title>A1: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, Hepatitis C virus (HCV) genotype (GT)1-infected non-cirrhotic (NC) participants took grazoprevir (GZR) 100 mg + uprifosbuvir (UPR) 300 mg + elbasvir (EBR) 50 mg once daily (q.d.) by mouth for 8 weeks.</description>
          </group>
          <group group_id="O2">
            <title>A2: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 300 mg + ruzasvir (RZR) 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O3">
            <title>A3: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O4">
            <title>A4: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O5">
            <title>A5: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O6">
            <title>A6: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O7">
            <title>B6: GT1 NC GZR+UPR+RVR (8 Weeks)</title>
            <description>In Part B, HCV GT1-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O8">
            <title>A7: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O9">
            <title>A8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O10">
            <title>B8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O11">
            <title>B9: GT1 NC GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT1-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O12">
            <title>B10: GT2 NC GZR+UPR+RZR (8 Weeks) + RBV</title>
            <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
          </group>
          <group group_id="O13">
            <title>B11: GT2 NC GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O14">
            <title>B12: GT1 C GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O15">
            <title>B13: GT1 C GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O16">
            <title>B14: GT2 C GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O17">
            <title>B15: GT2 C GZR+UPR+RZR (12 Weeks) + RBV</title>
            <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
          </group>
          <group group_id="O18">
            <title>16: GT2 C GZR+UPR+RZR (16 Weeks)</title>
            <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 16 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Experiencing an Adverse Event (AE)</title>
          <description>An AE is defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment.</description>
          <population>All randomized participants who received at least 1 dose of study drug are included.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="23"/>
                <count group_id="O6" value="23"/>
                <count group_id="O7" value="30"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="16"/>
                <count group_id="O10" value="16"/>
                <count group_id="O11" value="48"/>
                <count group_id="O12" value="31"/>
                <count group_id="O13" value="31"/>
                <count group_id="O14" value="35"/>
                <count group_id="O15" value="40"/>
                <count group_id="O16" value="15"/>
                <count group_id="O17" value="16"/>
                <count group_id="O18" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.9"/>
                    <measurement group_id="O2" value="83.3"/>
                    <measurement group_id="O3" value="56.3"/>
                    <measurement group_id="O4" value="71.4"/>
                    <measurement group_id="O5" value="73.9"/>
                    <measurement group_id="O6" value="60.9"/>
                    <measurement group_id="O7" value="62.3"/>
                    <measurement group_id="O8" value="86.7"/>
                    <measurement group_id="O9" value="75.0"/>
                    <measurement group_id="O10" value="68.8"/>
                    <measurement group_id="O11" value="72.9"/>
                    <measurement group_id="O12" value="80.6"/>
                    <measurement group_id="O13" value="71.0"/>
                    <measurement group_id="O14" value="57.1"/>
                    <measurement group_id="O15" value="72.5"/>
                    <measurement group_id="O16" value="53.3"/>
                    <measurement group_id="O17" value="81.3"/>
                    <measurement group_id="O18" value="69.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Achieving Sustained Virologic Response 24 Weeks After Ending Study Treatment (SVR24)</title>
        <description>The percentage of participants with HCV RNA &lt; LLoQ 24 weeks after completing treatment (i.e., SVR24) in each arm was determined. Plasma levels of HCV RNA levels were measured using the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV Test, v2.0 assay, which has a LLoQ of 15 IU/mL.</description>
        <time_frame>Up to 40 weeks</time_frame>
        <population>All randomized participants who received at least 1 dose of study drug and had SVR24 results available are included.</population>
        <group_list>
          <group group_id="O1">
            <title>A1: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, Hepatitis C virus (HCV) genotype (GT)1-infected non-cirrhotic (NC) participants took grazoprevir (GZR) 100 mg + uprifosbuvir (UPR) 300 mg + elbasvir (EBR) 50 mg once daily (q.d.) by mouth for 8 weeks.</description>
          </group>
          <group group_id="O2">
            <title>A2: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 300 mg + ruzasvir (RZR) 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O3">
            <title>A3: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O4">
            <title>A4: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O5">
            <title>A5: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O6">
            <title>A6: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O7">
            <title>B6: GT1 NC GZR+UPR+RVR (8 Weeks)</title>
            <description>In Part B, HCV GT1-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O8">
            <title>A7: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O9">
            <title>A8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O10">
            <title>B8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O11">
            <title>B9: GT1 NC GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT1-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O12">
            <title>B10: GT2 NC GZR+UPR+RZR (8 Weeks) + RBV</title>
            <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
          </group>
          <group group_id="O13">
            <title>B11: GT2 NC GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O14">
            <title>B12: GT1 C GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O15">
            <title>B13: GT1 C GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O16">
            <title>B14: GT2 C GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O17">
            <title>B15: GT2 C GZR+UPR+RZR (12 Weeks) + RBV</title>
            <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
          </group>
          <group group_id="O18">
            <title>16: GT2 C GZR+UPR+RZR (16 Weeks)</title>
            <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 16 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving Sustained Virologic Response 24 Weeks After Ending Study Treatment (SVR24)</title>
          <description>The percentage of participants with HCV RNA &lt; LLoQ 24 weeks after completing treatment (i.e., SVR24) in each arm was determined. Plasma levels of HCV RNA levels were measured using the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV Test, v2.0 assay, which has a LLoQ of 15 IU/mL.</description>
          <population>All randomized participants who received at least 1 dose of study drug and had SVR24 results available are included.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="23"/>
                <count group_id="O6" value="22"/>
                <count group_id="O7" value="30"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="16"/>
                <count group_id="O10" value="16"/>
                <count group_id="O11" value="48"/>
                <count group_id="O12" value="30"/>
                <count group_id="O13" value="29"/>
                <count group_id="O14" value="35"/>
                <count group_id="O15" value="35"/>
                <count group_id="O16" value="15"/>
                <count group_id="O17" value="16"/>
                <count group_id="O18" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O3" value="68.8" lower_limit="41.3" upper_limit="89.0"/>
                    <measurement group_id="O4" value="71.4" lower_limit="41.9" upper_limit="91.6"/>
                    <measurement group_id="O5" value="100.0" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O6" value="90.9" lower_limit="70.8" upper_limit="98.9"/>
                    <measurement group_id="O7" value="100.0" lower_limit="88.4" upper_limit="100.0"/>
                    <measurement group_id="O8" value="60.0" lower_limit="32.3" upper_limit="83.7"/>
                    <measurement group_id="O9" value="93.8" lower_limit="69.8" upper_limit="99.8"/>
                    <measurement group_id="O10" value="87.5" lower_limit="61.7" upper_limit="98.4"/>
                    <measurement group_id="O11" value="100.0" lower_limit="92.6" upper_limit="100.0"/>
                    <measurement group_id="O12" value="83.3" lower_limit="65.3" upper_limit="94.4"/>
                    <measurement group_id="O13" value="100.0" lower_limit="88.1" upper_limit="100.0"/>
                    <measurement group_id="O14" value="97.1" lower_limit="85.1" upper_limit="99.9"/>
                    <measurement group_id="O15" value="100.0" lower_limit="90.1" upper_limit="100.0"/>
                    <measurement group_id="O16" value="100.0" lower_limit="78.2" upper_limit="100.0"/>
                    <measurement group_id="O17" value="100.0" lower_limit="79.4" upper_limit="100.0"/>
                    <measurement group_id="O18" value="100.0" lower_limit="86.3" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Discontinuing From Study Treatment Due to an AE</title>
        <description>An AE is defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment.</description>
        <time_frame>Up to 16 weeks</time_frame>
        <population>All randomized participants who received at least 1 dose of study drug are included.</population>
        <group_list>
          <group group_id="O1">
            <title>A1: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, Hepatitis C virus (HCV) genotype (GT)1-infected non-cirrhotic (NC) participants took grazoprevir (GZR) 100 mg + uprifosbuvir (UPR) 300 mg + elbasvir (EBR) 50 mg once daily (q.d.) by mouth for 8 weeks.</description>
          </group>
          <group group_id="O2">
            <title>A2: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 300 mg + ruzasvir (RZR) 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O3">
            <title>A3: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O4">
            <title>A4: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O5">
            <title>A5: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O6">
            <title>A6: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O7">
            <title>B6: GT1 NC GZR+UPR+RVR (8 Weeks)</title>
            <description>In Part B, HCV GT1-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O8">
            <title>A7: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O9">
            <title>A8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O10">
            <title>B8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O11">
            <title>B9: GT1 NC GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT1-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O12">
            <title>B10: GT2 NC GZR+UPR+RZR (8 Weeks) + RBV</title>
            <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
          </group>
          <group group_id="O13">
            <title>B11: GT2 NC GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O14">
            <title>B12: GT1 C GZR+UPR+RZR (8 Weeks)</title>
            <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
          </group>
          <group group_id="O15">
            <title>B13: GT1 C GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O16">
            <title>B14: GT2 C GZR+UPR+RZR (12 Weeks)</title>
            <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
          </group>
          <group group_id="O17">
            <title>B15: GT2 C GZR+UPR+RZR (12 Weeks) + RBV</title>
            <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
          </group>
          <group group_id="O18">
            <title>16: GT2 C GZR+UPR+RZR (16 Weeks)</title>
            <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 16 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Discontinuing From Study Treatment Due to an AE</title>
          <description>An AE is defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment.</description>
          <population>All randomized participants who received at least 1 dose of study drug are included.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="23"/>
                <count group_id="O6" value="23"/>
                <count group_id="O7" value="30"/>
                <count group_id="O8" value="15"/>
                <count group_id="O9" value="16"/>
                <count group_id="O10" value="16"/>
                <count group_id="O11" value="48"/>
                <count group_id="O12" value="31"/>
                <count group_id="O13" value="31"/>
                <count group_id="O14" value="35"/>
                <count group_id="O15" value="40"/>
                <count group_id="O16" value="15"/>
                <count group_id="O17" value="16"/>
                <count group_id="O18" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="6.5"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="2.5"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="12.5"/>
                    <measurement group_id="O18" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 18 weeks (14 days after completing treatment)</time_frame>
      <desc>All participants who received at least 1 dose of study drug are included.</desc>
      <group_list>
        <group group_id="E1">
          <title>A1: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
          <description>In Part A, Hepatitis C virus (HCV) genotype (GT)1-infected non-cirrhotic (NC) participants took grazoprevir (GZR) 100 mg + uprifosbuvir (UPR) 300 mg + elbasvir (EBR) 50 mg once daily (q.d.) by mouth for 8 weeks.</description>
        </group>
        <group group_id="E2">
          <title>A2: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 300 mg + ruzasvir (RZR) 60 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="E3">
          <title>A3: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
          <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="E4">
          <title>A4: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 300 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="E5">
          <title>A5: GT1 NC GZR+UPR+EBR (8 Weeks)</title>
          <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="E6">
          <title>A6: GT1 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part A, HCV GT1-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="E7">
          <title>A7: GT2 NC GZR+UPR+EBR (8 Weeks)</title>
          <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + EBR 50 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="E8">
          <title>A8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part A, HCV GT2-infected NC participants took GZR 100 mg + UPR 450 mg + RZR 60 mg q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="E9">
          <title>B6: GT1 NC GZR+UPR+RVR (8 Weeks)</title>
          <description>In Part B, HCV GT1-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="E10">
          <title>B8: GT2 NC GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="E11">
          <title>B9: GT1 NC GZR+UPR+RZR (12 Weeks)</title>
          <description>In Part B, HCV GT1-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
        </group>
        <group group_id="E12">
          <title>B10: GT2 NC GZR+UPR+RZR (8 Weeks) + RBVMax 62 Characters...</title>
          <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
        </group>
        <group group_id="E13">
          <title>B11: GT2 NC GZR+UPR+RZR (12 Weeks)</title>
          <description>In Part B, HCV GT2-infected NC participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
        </group>
        <group group_id="E14">
          <title>B12: GT1 C GZR+UPR+RZR (8 Weeks)</title>
          <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 8 weeks.</description>
        </group>
        <group group_id="E15">
          <title>B13: GT1 C GZR+UPR+RZR (12 Weeks)</title>
          <description>In Part B, HCV GT1-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
        </group>
        <group group_id="E16">
          <title>B14: GT2 C GZR+UPR+RZR (12 Weeks)</title>
          <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks.</description>
        </group>
        <group group_id="E17">
          <title>B15: GT2 C GZR+UPR+RZR (12 Weeks) + RBV</title>
          <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing GZR 50 mg + UPR 225 mg + RZR 30 mg per tablet q.d. by mouth for 12 weeks. Participants will also take RBV b.i.d. at a total daily dose of 800-1600 mg based on body weight.</description>
        </group>
        <group group_id="E18">
          <title>B16: GT2 C GZR+UPR+RZR (16 Weeks)</title>
          <description>In Part B, HCV GT2-infected C participants took 2 FDC tablets containing UPR 225 mg + GZR 50 mg + RZR 30 mg per tablet q.d. by mouth for 16 weeks.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 19.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pilonidal cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Substance-induced psychotic disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 19.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="16"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="23"/>
                <counts group_id="E6" subjects_affected="13" subjects_at_risk="23"/>
                <counts group_id="E7" subjects_affected="13" subjects_at_risk="15"/>
                <counts group_id="E8" subjects_affected="12" subjects_at_risk="16"/>
                <counts group_id="E9" subjects_affected="18" subjects_at_risk="30"/>
                <counts group_id="E10" subjects_affected="11" subjects_at_risk="16"/>
                <counts group_id="E11" subjects_affected="35" subjects_at_risk="48"/>
                <counts group_id="E12" subjects_affected="24" subjects_at_risk="31"/>
                <counts group_id="E13" subjects_affected="19" subjects_at_risk="31"/>
                <counts group_id="E14" subjects_affected="19" subjects_at_risk="35"/>
                <counts group_id="E15" subjects_affected="26" subjects_at_risk="40"/>
                <counts group_id="E16" subjects_affected="8" subjects_at_risk="15"/>
                <counts group_id="E17" subjects_affected="13" subjects_at_risk="16"/>
                <counts group_id="E18" subjects_affected="14" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="4" subjects_affected="3" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="2" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="3" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Excessive cerumen production</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="3" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Androgen deficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blepharospasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="2" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="4" subjects_affected="4" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E9" events="3" subjects_affected="3" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="5" subjects_affected="5" subjects_at_risk="48"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="3" subjects_affected="3" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="3" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="3" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gingival pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="8" subjects_affected="6" subjects_at_risk="15"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E9" events="5" subjects_affected="5" subjects_at_risk="30"/>
                <counts group_id="E10" events="3" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E11" events="7" subjects_affected="7" subjects_at_risk="48"/>
                <counts group_id="E12" events="6" subjects_affected="5" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E18" events="4" subjects_affected="4" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E18" events="3" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Epigastric discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="5" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E18" events="2" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Crying</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Drug withdrawal syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Energy increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="23"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E5" events="6" subjects_affected="6" subjects_at_risk="23"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="23"/>
                <counts group_id="E7" events="6" subjects_affected="6" subjects_at_risk="15"/>
                <counts group_id="E8" events="6" subjects_affected="6" subjects_at_risk="16"/>
                <counts group_id="E9" events="4" subjects_affected="4" subjects_at_risk="30"/>
                <counts group_id="E10" events="4" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E11" events="9" subjects_affected="8" subjects_at_risk="48"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="3" subjects_affected="3" subjects_at_risk="35"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="5" subjects_affected="5" subjects_at_risk="16"/>
                <counts group_id="E18" events="4" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Feeling cold</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vessel puncture site reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="3" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="3" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="3" subjects_affected="2" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gingivitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="3" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="4" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="4" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="2" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Oral herpes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="2" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Sialoadenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="3" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="3" subjects_affected="3" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Sunburn</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="3" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT prolonged</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lipase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Liver function test increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pulse abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Increased appetite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="4" subjects_affected="3" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="3" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E11" events="2" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="3" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="3" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="3" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="3" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="2" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Disturbance in attention</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="5" subjects_affected="4" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="5" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="23"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E5" events="9" subjects_affected="8" subjects_at_risk="23"/>
                <counts group_id="E6" events="4" subjects_affected="3" subjects_at_risk="23"/>
                <counts group_id="E7" events="5" subjects_affected="5" subjects_at_risk="15"/>
                <counts group_id="E8" events="10" subjects_affected="9" subjects_at_risk="16"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E11" events="25" subjects_affected="15" subjects_at_risk="48"/>
                <counts group_id="E12" events="8" subjects_affected="8" subjects_at_risk="31"/>
                <counts group_id="E13" events="7" subjects_affected="7" subjects_at_risk="31"/>
                <counts group_id="E14" events="6" subjects_affected="5" subjects_at_risk="35"/>
                <counts group_id="E15" events="11" subjects_affected="5" subjects_at_risk="40"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E18" events="10" subjects_affected="4" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Affective disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="3" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E12" events="3" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Flat affect</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Initial insomnia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="3" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E9" events="3" subjects_affected="3" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="5" subjects_affected="4" subjects_at_risk="48"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="31"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Libido decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Mood altered</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Sleep disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Renal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Erectile dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Menstruation delayed</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="3" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E12" events="5" subjects_affected="4" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="3" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Respiratory tract congestion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Throat irritation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Macule</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="5" subjects_affected="5" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pruritus generalised</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="3" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E12" events="5" subjects_affected="3" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E16" events="2" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Rash papular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vitiligo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E14" events="3" subjects_affected="3" subjects_at_risk="35"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Essential hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior VIce President, Global Clinical Development</name_or_title>
      <organization>Merck Sharp &amp; Dohme Corp.</organization>
      <phone>1-800-672-6372</phone>
      <email>ClinicalTrialsDisclosure@merck.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

